Roche secures Zealand obesity drug candidate for up to $5.3 billion Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion ...
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in ...
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on Roche Holding AG (RHHVF – Research Report), with a price ...
Shares of Roche Holding AG (OTCMKTS:RHHBY – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six brokerages that are presently covering the firm, Marketbeat.com reports ...
J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback